PAR 2.13% 24.0¢ paradigm biopharmaceuticals limited..

@wazza239 , Nobody gets control of another entity in business,...

  1. 660 Posts.
    lightbulb Created with Sketch. 122
    @wazza239 , Nobody gets control of another entity in business, all you get is legal protection. When they deal with PAR, they are sort of getting the partnership of PAR and Bene in this venture. They are all interdependent. Even if BP wanted to gain control by buying out Bene, they would still have to honour existing contracts with PAR or anyone else. I think as we get closer to commercialisation the FOMO will overtake any nervousness about us appearing to be a middle man between them and the drug.
    Last edited by Babbanap: 06/04/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.005(2.13%)
Mkt cap ! $80.45M
Open High Low Value Volume
23.0¢ 24.0¢ 23.0¢ $24.48K 104.4K

Buyers (Bids)

No. Vol. Price($)
5 20867 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 60034 7
View Market Depth
Last trade - 13.11pm 04/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.